TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Wisconsin Investigators

Robert Delaune, MD

Mercy Regional Cancer Center


Janesville, Wisconsin - 53547 (952-993-1517)
  • CLINICAL TRIALS 12
  • CONDITIONS21
  • INTERVENTIONS27
  • SINCE2005
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement

March 2009 - May 2015
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

June 2008 - December 2009
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

June 2010 - February 2013
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

April 2008 - January 2010
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer

October 2008 - October 2010
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

November 2008 - August 2011
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

May 2008 - February 2009
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

June 2007 - January 2010
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Adenocarcinoma

Prostatic Neoplasms

Multiple Myeloma

Neoplasms, Plasma Cell

Neoplasms

Neoplasm Metastasis

Carcinoma

Carcinoma, Non-Small-Cell Lung

Neurotoxicity Syndromes

Colorectal Neoplasms

Peripheral Nervous System Diseases

Demyelinating Diseases

Polyneuropathies

Neurologic Manifestations

Carcinoma in Situ

Carcinoma, Intraductal, Noninfiltrating

Carcinoma, Ductal, Breast

Carcinoma, Ductal

Placebo

Zoledronic Acid

Celecoxib

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Gemcitabine Hydrochloride

Cyclophosphamide

Radiation Therapy

Pemetrexed Disodium

Oxaliplatin

Doxorubicin Hydrochloride

Sunitinib Malate

Trastuzumab

Cetuximab

Tamoxifen Citrate

Irinotecan Hydrochloride

Ixabepilone

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Letrozole

Ac Regimen

Duloxetine Hydrochloride

Vinorelbine Ditartrate

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo